Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Veno-occlusive disease of the liver induced by gemcitabine.

× No keyword cloud information.

8 in total

1. Severe cholestatic liver failure associated with gemcitabine adjuvant monotherapy for pancreatic cancer.

Authors: Takaho Okada; Shinichi Egawa; Fuyuhiko Motoi; Kuniharu Yamamoto; Shigeru Ottomo; Naoaki Sakata; Toshiki Rikiyama; Yu Katayose; Michiaki Unno
Journal: Clin J Gastroenterol Date: 2011-10-01

2. Acute liver failure secondary to gemcitabine.

Authors: Alice Stellman; Mei Mei Loke; Steven Mann
Journal: BMJ Case Rep Date: 2010-04-22

3. A fatal case of progressive steatohepatitis, possibly chemotherapy-associated steatohepatitis related to gemcitabine.

Authors: Xiang Shan Ren; Kenichi Harada; Seiichi Yoshikawa; Saya Igarashi; Takeshi Urabe; Shinya Yamada; Kazuyoshi Katayanagi; Hiroshi Kurumaya; Yasuni Nakanuma
Journal: Clin J Gastroenterol Date: 2010-06-22

4. Fatal cholestatic liver failure associated with gemcitabine therapy.

Authors: Keith Robinson; Louis Lambiase; Jianjun Li; Carmela Monteiro; Michael Schiff
Journal: Dig Dis Sci Date: 2003-09 Impact factor: 3.199

5. Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.

Authors: Soonmo Peter Kang; Tamar Taddei; Bruce McLennan; Jill Lacy
Journal: World J Gastroenterol Date: 2008-03-14 Impact factor: 5.742

6. Gemcitabine-induced vasculitis in advanced transitional cell carcinoma of the bladder.

Authors: M Birlik; S Akar; E Tuzel; F Onen; E Ozer; M Manisali; Z Kirkali; N Akkoc
Journal: J Cancer Res Clin Oncol Date: 2004-01-27 Impact factor: 4.553

7. Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.

Authors: S Serke; H Riess; H Oettle; D Huhn
Journal: Br J Cancer Date: 1999-03 Impact factor: 7.640

8. Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer.

Authors: C Barlow; M Nystrom; C Oesterling; D Fennell; J Ismay; C Gallagher
Journal: Br J Cancer Date: 2004-04-05 Impact factor: 7.640

8 in total